CorMedix Inc.
CRMD
$8.13
-$0.05-0.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 265.86% | 953.61% | 1,009.40% | 452.12% | 196.32% |
| Total Depreciation and Amortization | 6,483.67% | 5,437.81% | 4,593.29% | 2,081.42% | 296.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 151.71% | 63.00% | -259.41% | -865.77% | 46.48% |
| Change in Net Operating Assets | 128.82% | 46.11% | 118.44% | -170.73% | -676.04% |
| Cash from Operations | 733.59% | 1,557.07% | 445.84% | 234.48% | 159.97% |
| Capital Expenditure | -6,423.01% | -4,504.17% | -1,848.19% | -36.86% | 86.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 284.21% | -48.84% | -89.04% | -106.57% | -191.74% |
| Cash from Investing | -1,884.92% | -2,624.75% | -1,552.74% | -1,509.82% | -194.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.66% | 168.72% | 262.84% | 556.16% | 160.34% |
| Repurchase of Common Stock | -1,405.49% | -1,021.17% | -585.34% | -653.80% | -457.65% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.30% | 577.55% | 806.01% | 1,520.18% | 158.76% |
| Foreign Exchange rate Adjustments | -900.00% | 100.00% | 100.00% | -110.53% | 83.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.86% | 263.13% | 3,525.91% | 177.81% | 1,393.46% |